|
ZNF445 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.83659778893752E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.54951656745106E-15 |
| Normal-vs-Stage2 |
5.28850000014458E-07 |
| Normal-vs-Stage3 |
7.7937656328686E-14 |
| Normal-vs-Stage4 |
3.06290548479637E-11 |
| Stage1-vs-Stage2 |
5.052000E-01 |
| Stage1-vs-Stage3 |
1.739200E-01 |
| Stage1-vs-Stage4 |
1.604950E-01 |
| Stage2-vs-Stage3 |
1.267210E-01 |
| Stage2-vs-Stage4 |
9.416100E-02 |
| Stage3-vs-Stage4 |
7.300800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.83250114871703E-11 |
| Normal-vs-AfricanAmerican |
4.3836999999991E-05 |
| Normal-vs-Asian |
1.42280000003936E-08 |
| Caucasian-vs-AfricanAmerican |
5.430200E-01 |
| Caucasian-vs-Asian |
6.816800E-01 |
| AfricanAmerican-vs-Asian |
7.817200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.71358499506869E-12 |
| Normal-vs-Female |
4.58300064565265E-11 |
| Male-vs-Female |
7.363800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74849024148216E-12 |
| Normal-vs-Age(41-60Yrs) |
9.65894031423886E-15 |
| Normal-vs-Age(61-80Yrs) |
2.66070498966542E-11 |
| Normal-vs-Age(81-100Yrs) |
7.154500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.238000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.321200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.370600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.484600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.931600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.670800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.917700E-03 |
| Classical-VS-Follicular |
1.486640E-01 |
| Classical-VS-Other |
4.650000E-01 |
| Classical-VS-Normal |
3.489500022269E-09 |
| Tall-VS-Follicular |
7.331700E-02 |
| Tall-VS-Other |
4.410000E-01 |
| Tall-VS-Normal |
3.43947093028873E-12 |
| Follicular-VS-Other |
8.780200E-01 |
| Follicular-VS-Normal |
9.57389723055257E-11 |
| Other-VS-Normal |
3.061200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30606677987089E-14 |
| Normal-vs-N1 |
7.20430382017412E-11 |
| N0-vs-N1 |
2.530200E-01 |
|
|
